Page 392 - கடுமையானது எடுப்போசை சுவாச நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Army Begins Clinical Trials on Vaccine That May Be Effective Against All Coronaviruses Officer receives the Pfizer-BioNTech COVID-19 vaccine at the Conroy Bowl on Schofield Barracks, Hawaii on Jan. 14, 2021. (U.S. Army/1st Lt. Angelo Mejia) 6 Apr 2021 Fifteen months after launching an effort to develop a vaccine against COVID-19, the Walter Reed Army Institute of Research is preparing for a clinical trial, seeking volunteers for a small safety study. The Army s vaccine candidate uses a new technology involving a Spike Ferritin Nanoparticle, or SpFN, that researchers hope can be adapted to protect against any coronavirus, including those that cause the common cold or deadly diseases such as COVID-19, Severe Acute Respiratory Syndrome, or SARS, and Middle East Respiratory Syndrome, MERS.

United statesKayvon modjarradJoe bidenCenters for diseaseJohns hopkins universityWalter reed army institute of researchInfectious diseases branchClinical trials centerDefense departmentArmy medical researchWalter reed army instituteSpike ferritin nanoparticleSevere acute respiratory syndromeMiddle east respiratory syndromeEmerging infectious diseases branchTrials center